Ohara Pharmaceutical

MyDawa is an innovative online pharmacy that facilitates the purchase of a wide range of high-quality medications and wellness products through a mobile platform. By connecting patients directly to drug stores, MyDawa provides a convenient solution for accessing essential health products without incurring service fees, transaction costs, or delivery charges. This approach aims to make medications more affordable and accessible while addressing the challenges present in the pharmaceutical supply chain.

Africa Healthcare Network (“AHN”) has established the first dialysis chain across Sub-Saharan Africa, providing high-quality, life-saving dialysis at affordable cost. AHN brings world-class technical expertise combined with developing world practical operating experience to a region in dire need of quality dialysis treatment. Dialysis is a life-saving treatment for patients with Acute Kidney Injury (AKI) and End-Stage Renal Disease (ESRD). The few hospitals that provide treatment operate centers that are slowly deteriorating while charging prohibitive prices. Additionally, the lack of trained professionals and limited capital investment in care for non-communicable diseases in Sub-Saharan Africa, dialysis centers are few and far between, causing patients to endure the high costs for travel to receive care. Those who cannot afford the costs of treatment and travel are resigned to death. Chronic Kidney Disease (CKD) and AKI are on the rise in the region due to strong epidemiologic factors, including increased urbanization leading to lifestyle diseases, other non-communicable diseases, HIV and other infections and toxins. Utilizing our network of executives/partners, we will secure high-quality equipment and train professionals to provide superior care. Our ability to source lowest cost consumables, operational efficiency and scale, will allow us to lower the cost to patients. The net result is increased access, higher quality and lower cost to patients, while maintaining profitability. AHN operates in Rwanda, Tanzania and Kenya.

Africa Healthcare Network (“AHN”) has established the first dialysis chain across Sub-Saharan Africa, providing high-quality, life-saving dialysis at affordable cost. AHN brings world-class technical expertise combined with developing world practical operating experience to a region in dire need of quality dialysis treatment. Dialysis is a life-saving treatment for patients with Acute Kidney Injury (AKI) and End-Stage Renal Disease (ESRD). The few hospitals that provide treatment operate centers that are slowly deteriorating while charging prohibitive prices. Additionally, the lack of trained professionals and limited capital investment in care for non-communicable diseases in Sub-Saharan Africa, dialysis centers are few and far between, causing patients to endure the high costs for travel to receive care. Those who cannot afford the costs of treatment and travel are resigned to death. Chronic Kidney Disease (CKD) and AKI are on the rise in the region due to strong epidemiologic factors, including increased urbanization leading to lifestyle diseases, other non-communicable diseases, HIV and other infections and toxins. Utilizing our network of executives/partners, we will secure high-quality equipment and train professionals to provide superior care. Our ability to source lowest cost consumables, operational efficiency and scale, will allow us to lower the cost to patients. The net result is increased access, higher quality and lower cost to patients, while maintaining profitability. AHN operates in Rwanda, Tanzania and Kenya.

Helium Health focuses on transforming healthcare in Africa by providing a comprehensive suite of software tools for hospitals and clinics. The company develops an electronic health record platform that simplifies patient record management and hospital operations. Its services include digitizing medical records, managing appointments and prescriptions, and facilitating medical billing through a user-friendly interface accessible from any device. Additionally, Helium Health offers customizable forms, trend monitoring, alert triggers, and report generation, enabling healthcare providers to enhance their practice efficiency and improve patient care. By leveraging technology, Helium Health aims to establish the largest healthcare data exchange in Africa, contributing to a modern and affordable healthcare system.

Revital Healthcare is a manufacturer of medical devices and disposables for hospitals and other medical laboratories. It offers single-use syringes, needles, re-use prevention syringes and auto-disable syringes which helps in reducing the transmission of HIV and other blood-borne diseases along with infusion sets, blood transfusion sets and blood collection tubes The company was established in 2006 and is headquartered in Kilifi, Kenya.

HACARUS is a provider of Explainable Lightweight AI Tools, backed by Miyako Capital (Kyoto University) among others. Its solutions are used in the Medical and Manufacturing fields to enable humans to make better, faster and more reliable decisions, based on AI driven insights. Hacarus' proprietary AI engine is built using Sparse Modeling, an AI method that understands data like a human would - by its unique key features and is far more resource, time and energy efficient when compared to Deep Learning.

J-Pharma is a pharmaceutical company focused on developing novel drugs through a human-genomic approach, specifically targeting cell membrane transporters associated with various diseases. The company aims to create selective agents for treating conditions such as cancer by developing anti-cancer drugs and PET diagnostic agents that interact with transporters like LAT1, which are linked to cancer cell growth. J-Pharma's research emphasizes the importance of understanding drug transporters to enhance the pharmacokinetics of new drug candidates. By discovering key transporters within the human body, J-Pharma seeks to advance diagnostic methods and improve treatment options, thereby contributing to global health and enhancing the quality of life for aging populations in industrialized countries.

Helium Health focuses on transforming healthcare in Africa by providing a comprehensive suite of software tools for hospitals and clinics. The company develops an electronic health record platform that simplifies patient record management and hospital operations. Its services include digitizing medical records, managing appointments and prescriptions, and facilitating medical billing through a user-friendly interface accessible from any device. Additionally, Helium Health offers customizable forms, trend monitoring, alert triggers, and report generation, enabling healthcare providers to enhance their practice efficiency and improve patient care. By leveraging technology, Helium Health aims to establish the largest healthcare data exchange in Africa, contributing to a modern and affordable healthcare system.

Prism BioLab is focused on drug discovery and development, utilizing its proprietary PepMetics Technology to create therapeutic agents. The company specializes in treatments for non-oncology indications, particularly targeting conditions such as pulmonary fibrosis and other incurable diseases. By leveraging its innovative platform, Prism BioLab aims to provide effective solutions for these challenging health issues.

HekaBio is a healthcare development and investment platform focused on advancing innovations in oncology, radiation, and cardiovascular therapies. The company specializes in offering a wide range of development expertise, including pharmaceuticals, medical devices, in-vitro diagnostics, digital health, and cell and gene therapies. HekaBio aims to support researchers in advancing breakthrough programs while facilitating accelerated access to global healthcare innovations for patients. By investing in and commercializing these healthcare technologies, HekaBio plays a crucial role in improving treatment options for oncology and fibrotic diseases.

HACARUS is a provider of Explainable Lightweight AI Tools, backed by Miyako Capital (Kyoto University) among others. Its solutions are used in the Medical and Manufacturing fields to enable humans to make better, faster and more reliable decisions, based on AI driven insights. Hacarus' proprietary AI engine is built using Sparse Modeling, an AI method that understands data like a human would - by its unique key features and is far more resource, time and energy efficient when compared to Deep Learning.

Jiksak Bioengineering, Inc. is a biotechnology company based in Kawasaki, Japan, founded in 2017. The company specializes in developing microfluidic devices that utilize in vivo nerve reproduction for drug screening services, particularly focusing on neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Parkinson's disease. Jiksak Bioengineering employs a unique technology centered around three-dimensional cell tissues known as Nerve Organoids, which enhance the efficiency of drug screening processes. By creating nerve tissue products that closely resemble human nerve tissue, the company aims to facilitate the identification and development of effective treatments for neurodegenerative disorders, ultimately supporting medical professionals in their therapeutic efforts.